Loading
A phase 2 trial of Choline C-11 in Hepatocellular carcinoma, run by Commissariat A L'energie Atomique, with a status the registry has not verified recently.
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma is a phase 2 interventional study registered as NCT01377220 by Commissariat A L'energie Atomique, with 30 participants planned, started 2011-06 and due to reach its primary completion in 2013-06. Interventions recorded: 11C-Choline. Conditions recorded: Hepatocellular Carcinoma.
Linked to the drug Choline C-11 because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Shares Choline C-11 and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.